German biotech company Sigma-Aldrich is the target of additional charges over alleged false information submitted to EU officials during a merger deal involving Merck KGaA.The European Commission said today it had issued a supplementary Statement of Objections, replacing a 2017 charge sheet to focus just on Sigma (see here).Merck won EU approval